| As03 Injection 2.5 mL | 58160-0855-19 | As03 | - | Injection |
| Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine 25 [iU] / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL; 40 [iU] / .5mL; 8 [iU] / .5mL; 32 [iU] / .5mL Injection 0.5 mL (Kinrix) | 58160-0812-52 | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine | 25 [iU] / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL; 40 [iU] / .5mL; 8 [iU] / .5mL; 32 [iU] / .5mL | Injection |
| Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL; 10 ug / .5mL; 40 [iU] / .5mL; 8 [iU] / .5mL; 32 [iU] / .5mL Injection 0.5 mL (Pediarix) | 58160-0811-52 | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined | 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL; 10 ug / .5mL; 40 [iU] / .5mL; 8 [iU] / .5mL; 32 [iU] / .5mL | Injection |
| Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL Suspension 0.5 mL (Infanrix) | 58160-0810-52 | Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed | 25 ug / .5mL; 8 ug / .5mL; 25 ug / .5mL; 10 [iU] / .5mL; 25 [iU] / .5mL | Suspension |
| Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) Kit 0.5 mL (Hiberix) | 58160-0818-11 | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | - | Kit |
| Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) Kit 1 Kit (Hiberix) | 58160-0726-15 | Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | - | Kit |
| Hepatitis A and Hepatitis B (Recombinant) Vaccine 720 [iU] / mL; 20 ug / mL Injection 1 mL (Twinrix) | 58160-0815-52 | Hepatitis A and Hepatitis B (Recombinant) Vaccine | 720 [iU] / mL; 20 ug / mL | Injection |
| Hepatitis A Vaccine 1440 [iU] / mL Injection 1 mL (Havrix) | 58160-0826-52 | Hepatitis A Vaccine | 1440 [iU] / mL | Injection |
| Hepatitis A Vaccine 720 [iU] / .5mL Injection 0.5 mL (Havrix) | 58160-0825-52 | Hepatitis A Vaccine | 720 [iU] / .5mL | Injection |
| Hepatitis B Vaccine (Recombinant) 10 ug / .5mL Injection 0.5 mL (Engerix-B) | 58160-0820-52 | Hepatitis B Vaccine (Recombinant) | 10 ug / .5mL | Injection |
| Hepatitis B Vaccine (Recombinant) 20 ug / mL Injection 1 mL (Engerix-B) | 58160-0821-11 | Hepatitis B Vaccine (Recombinant) | 20 ug / mL | Injection |
| Hepatitis B Vaccine (Recombinant) 20 ug / mL Injection 1 mL (Engerix-B) | 58160-0821-52 | Hepatitis B Vaccine (Recombinant) | 20 ug / mL | Injection |
| influenza virus vaccine, 2025/2026 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL Suspension 0.5 mL (Fluarix, 2025/2026) | 58160-0912-52 | influenza virus vaccine, 2025/2026 | 15 ug / .5mL; 15 ug / .5mL; 15 ug / .5mL | Suspension |
| Measels, Mumps, and Rubella Vaccine, Live Kit 1 Kit (Priorix) | 58160-0824-15 | Measels, Mumps, and Rubella Vaccine, Live | - | Kit |
| Meningococcal (Groups A, B, C, W and Y) Kit 1 Kit (Penmenvy) | 58160-0757-15 | Meningococcal (Groups A, B, C, W and Y) | - | Kit |
| Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 ug / .5mL; 5 ug / .5mL; 5 ug / .5mL; 5 ug / .5mL Injection 0.5 mL (Menveo) | 58160-0827-30 | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine | 10 ug / .5mL; 5 ug / .5mL; 5 ug / .5mL; 5 ug / .5mL | Injection |
| Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine Kit 1 Kit (Menveo) | 58160-0955-09 | Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine | - | Kit |
| NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN 50 ug / .5mL; 50 ug / .5mL; 50 ug / .5mL; 25 ug / .5mL Injection 0.5 mL (Bexsero) | 58160-0976-20 | NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN | 50 ug / .5mL; 50 ug / .5mL; 50 ug / .5mL; 25 ug / .5mL | Injection |
| Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted Kit 1 Kit (Arexvy) | 58160-0848-11 | Respiratory Syncytial Virus Vaccine Recombinant, Adjuvanted | - | Kit |
| Rotavirus Vaccine, Live, Oral 1000 [CCID_50] / mL Solution 1.5 mL (Rotarix) | 58160-0740-21 | Rotavirus Vaccine, Live, Oral | 1000 [CCID_50] / mL | Solution |
| Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed 8 ug / .5mL; 2.5 ug / .5mL; 8 ug / .5mL; 5 [iU] / .5mL; 2.5 [iU] / .5mL Suspension 0.5 mL (Boostrix) | 58160-0842-11 | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed | 8 ug / .5mL; 2.5 ug / .5mL; 8 ug / .5mL; 5 [iU] / .5mL; 2.5 [iU] / .5mL | Suspension |
| Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed 8 ug / .5mL; 2.5 ug / .5mL; 8 ug / .5mL; 5 [iU] / .5mL; 2.5 [iU] / .5mL Suspension 0.5 mL (Boostrix) | 58160-0842-52 | Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed | 8 ug / .5mL; 2.5 ug / .5mL; 8 ug / .5mL; 5 [iU] / .5mL; 2.5 [iU] / .5mL | Suspension |
| Zoster Vaccine Recombinant, Adjuvanted 50 ug / .5mL Injection 0.5 mL (Shingrix) | 58160-0849-52 | Zoster Vaccine Recombinant, Adjuvanted | 50 ug / .5mL | Injection |
| Zoster Vaccine Recombinant, Adjuvanted Kit 1 Kit (Shingrix) | 58160-0823-11 | Zoster Vaccine Recombinant, Adjuvanted | - | Kit |